Breast cancer Flashcards
1
Q
What is the keynote-522 regimen?
A
carbo/taxol (TC) + pembrolizumab, followed by doxorubicin/cyclophosphamide (AC)
1
Q
Adjuvant treatment of DCIS
A
- None if mastectomy
- ET after BCT is a risk/benefit discussion given no proven OS benefit.
IF ER+ (PR doesn’t matter) AND premenopausal → tamoxifen 20 mg daily for 5 years
IF ER+ and postmenopausal –> AI for 5 years